Eli Lilly has presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor agonist candidate brenipatide in substance use, psychiatric, and immunologic disorders—and ...

In his new book "Curved Air", Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in ...

Study identified age-related HGG patient groups that demonstrated distinct molecular profiles and survival outcomes, and were ...

Discovery could open up new avenues for studying diseases that affect the brainstem, such as spinal muscular atrophy and amyotrophic lateral sclerosis.

In kidney organoids, elevated glucose triggered tissue-intrinsic inflammation and epithelial cell detachment without overt cytotoxicity. Inhibiting MIF, TNF-alpha, or MAPK-related signaling helped ...

A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations.

A 12-week pilot study found time-restricted eating was safe and feasible for people with early Huntington’s disease.

Del-desiran was one of three clinical setbacks for Novartis within a week. On 4, Novartis and Ionis Pharmaceuticals ...

Findings provide some of the strongest human evidence to date that expansion of the Huntington mutation is a key factor in ...

Researchers at Virginia Tech have developed a prophylactic phage therapy approach to protecting against potential future ...

Researchers say that organoids have the potential to give researchers a more human-relevant view of disease and treatment response.

CloudScope, developed at Johns Hopkins, is a cloud-based microscope enabling continuous, remote brain imaging in freely ...